{"id":3240,"date":"2022-06-14T10:53:42","date_gmt":"2022-06-14T08:53:42","guid":{"rendered":"https:\/\/www.biopole-clermont.com\/?post_type=communiques&#038;p=3240"},"modified":"2022-06-14T10:53:42","modified_gmt":"2022-06-14T08:53:42","slug":"valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car","status":"publish","type":"communiques","link":"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/","title":{"rendered":"Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor."},"template":"","type_de_communiques_de_presse":[],"entreprise":[303],"zentreprise":[],"class_list":["post-3240","communiques","type-communiques","status-publish","hentry","entreprise-valbiotis-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor. - Biop\u00f4le Clermont-Limagne<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor. - Biop\u00f4le Clermont-Limagne\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/\" \/>\n<meta property=\"og:site_name\" content=\"Biop\u00f4le Clermont-Limagne\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/\",\"url\":\"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/\",\"name\":\"Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor. - Biop\u00f4le Clermont-Limagne\",\"isPartOf\":{\"@id\":\"https:\/\/www.biopole-clermont.com\/en\/#website\"},\"datePublished\":\"2022-06-14T08:53:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.biopole-clermont.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9s de presse\",\"item\":\"https:\/\/www.biopole-clermont.com\/en\/communiques\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biopole-clermont.com\/en\/#website\",\"url\":\"https:\/\/www.biopole-clermont.com\/en\/\",\"name\":\"Biop\u00f4le Clermont-Limagne\",\"description\":\"Technopole des sciences du vivant\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biopole-clermont.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor. - Biop\u00f4le Clermont-Limagne","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/","og_locale":"en_US","og_type":"article","og_title":"Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor. - Biop\u00f4le Clermont-Limagne","og_url":"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/","og_site_name":"Biop\u00f4le Clermont-Limagne","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/","url":"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/","name":"Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor. - Biop\u00f4le Clermont-Limagne","isPartOf":{"@id":"https:\/\/www.biopole-clermont.com\/en\/#website"},"datePublished":"2022-06-14T08:53:42+00:00","breadcrumb":{"@id":"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.biopole-clermont.com\/en\/communiques\/valbiotis-announces-the-major-success-of-the-phase-ii-heart-clinical-study-the-patented-plant-based-active-substance-totum070-proves-its-efficacy-against-hypercholesterolemia-a-car\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.biopole-clermont.com\/en\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9s de presse","item":"https:\/\/www.biopole-clermont.com\/en\/communiques\/"},{"@type":"ListItem","position":3,"name":"Valbiotis announces the major success of the Phase II \ufeffHEART clinical study: the patented plant-based active substance TOTUM\u2022070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor."}]},{"@type":"WebSite","@id":"https:\/\/www.biopole-clermont.com\/en\/#website","url":"https:\/\/www.biopole-clermont.com\/en\/","name":"Biop\u00f4le Clermont-Limagne","description":"Technopole des sciences du vivant","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biopole-clermont.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/communiques\/3240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/communiques"}],"about":[{"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/types\/communiques"}],"version-history":[{"count":1,"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/communiques\/3240\/revisions"}],"predecessor-version":[{"id":3241,"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/communiques\/3240\/revisions\/3241"}],"wp:attachment":[{"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/media?parent=3240"}],"wp:term":[{"taxonomy":"type_de_communiques_de_presse","embeddable":true,"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/type_de_communiques_de_presse?post=3240"},{"taxonomy":"entreprise","embeddable":true,"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/entreprise?post=3240"},{"taxonomy":"zentreprise","embeddable":true,"href":"https:\/\/www.biopole-clermont.com\/en\/wp-json\/wp\/v2\/zentreprise?post=3240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}